TSHR and cyclic hematopoiesis: The five most commonly mutated genes were DUOX2, DUOXA2, TG, TSHR, and TPO. Notably, a subset of CH patients eventually exhibited TCH, constituting 14.3% (13/91) of the clinical outcomes.